![Shield Therapeutics Plc](/common/images/company/L_STX.png)
The current STX market cap is 29.47M. The company's latest EPS is USD -0.0429 and P/E is -0.87.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | USD ($) | USD ($) | |
Total Revenue | 719k | 10.39M | 1.52M | 5.5M | 13.09M |
Operating Income | -9.04M | -2.15M | -20.29M | -49.75M | -31.33M |
Net Income | -8.8M | -2.63M | -19.68M | -49.79M | -33.29M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | USD ($) | USD ($) | |
Total Assets | 36.32M | 32.53M | 44.41M | 26.62M | 48.8M |
Total Liabilities | 4.17M | 2.25M | 3.72M | 20.07M | 33.77M |
Total Equity | 32.15M | 30.28M | 40.69M | 6.54M | 15.03M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | USD ($) | USD ($) | |
Operating | -4.07M | -1.4M | -18.26M | -22.59M | -37.13M |
Investing | -1.37M | -20k | -2.05M | -2.25M | -2.43M |
Financing | -203k | -47k | 27.71M | 8.53M | 49.66M |
Market Cap | 29.47M |
Price to Earnings Ratio | -0.87 |
Price to Sales Ratio | 2.22 |
Price to Cash Ratio | 2.08 |
Price to Book Ratio | 1.93 |
Dividend Yield | - |
Shares Outstanding | 775.43M |
Average Volume (1 week) | 2.39M |
Average Volume (1 Month) | 6.67M |
52 Week Change | -61.42% |
52 Week High | 12.75 |
52 Week Low | 1.075 |
Spread (Intraday) | 0.1 (2.63%) |
Company Name | Shield Therapeutics Plc |
Address |
northern design centre newcastle upon tyne NE8 3DF |
Website | https://www.shieldtherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.